| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724635 | 4,11-dihydroxy-1-(4-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl] amino}butyl)-1H-naphtho[2,3-f]indole-5,10-dione | 0.0297837393005856 | 0.32948798 |
| NSC 727086 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate | 0.0297837393005856 | 0.29697714 |
| NSC 731129 | 2-[3,4,5(trimethoxy)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0297837393005856 | 0.23952941 |
| NSC 736761 | 16-[3-(2-morpholin-1-yl ethoxy)benzylidene]-5-androstene-3b,17b-diol diacetate | 0.0297837393005856 | 0.12058634 |
| NSC 741237 | Null | 0.0297837393005856 | 0.30915339 |
| NSC 753189 | 3,5-dichloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide | 0.0297837393005856 | 0.21390305 |
| NSC 756188 | GSK718429A | 0.0297837393005856 | 0.10732882 |
| NSC 8985 | WLN: 1R D-I-R D1 &E &6/14 | 0.0297837393005856 | 0.1236515 |
| NSC 711885 | Null | 0.0321614375606954 | 0.26710218 |
| NSC 743694 | Null | 0.0321614375606954 | 0.34651442 |